Effect of Coenzyme Q10 in mitigating oxidative DNA damage in Down syndrome patients, a double blind randomized controlled trial

Neurobiology of Aging

Volumn 32, Issue 11, 2011, Pages 2103-2105

  Tiano, L ^a   Carnevali, P ^a   Padella, L ^a   Santoro, L ^a   Principi, F ^a   Bruge F ^a   Carle, F ^a   Gesuita, R ^a   Gabrielli, O ^a   Littarru, G P ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Coenzyme Q10; Comet assay; Down syndrome; Oxidative DNA damage

Indexed keywords

PLACEBO; UBIDECARENONE;

ANTIOXIDANT ACTIVITY; ARTICLE; CHILD; CLINICAL ARTICLE; COMET ASSAY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA DAMAGE; DOUBLE BLIND PROCEDURE; DOWN SYNDROME; DRUG EFFICACY; GEL ELECTROPHORESIS; HUMAN; NEUROPROTECTION; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; DNA DAMAGE; DOUBLE-BLIND METHOD; DOWN SYNDROME; HUMANS; OXIDATIVE STRESS; TREATMENT OUTCOME; UBIQUINONE;

EID: 80052630069     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2009.11.016     Document Type: Article

References (9)

1. Capone G.T. Down syndrome: advances in molecular biology and the neurosciences. J. Dev. Behav. Pediatr. 2001, 22:40-59.
2. Collins A.R., Oscoz A.A., Brunborg G., Gaivao I., Giovannelli L., Kruszewski M., Smith C.C., Stetina R. The comet assay: topical issues. Mutagenesis 2008, 23:143-151.
3. Maluf S.W., Erdtmann B. Genomic instability in Down syndrome and Fanconi anemia assessed by micronucleus analysis and single-cell gel electrophoresis. Cancer Genet. Cytogenet. 2001, 124:71-75.
4. Miles M.V., Patterson B.J., Chalfonte-Evans M.L., Horn P.S., Hickey F.J., Schapiro M.B., Steele P.E., Tang P.H., Hotze S.L. Coenzyme Q10 (ubiquinol-10) supplementation improves oxidative imbalance in children with trisomy 21. Pediatr. Neurol. 2007, 37:398-403.
5. Rachidi M., Lopes C. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms. Neurosci. Res. 2007, 59:349-369.
6. Seidl R., Greber S., Schuller E., Bernert G., Cairns N., Lubec G. Evidence against increased oxidative DNA-damage in Down syndrome. Neurosci. Lett. 1997, 235:137-140.
7. Tiano L., Padella L., Carnevali P., Gabrielli O., Bruge F., Principi F., Littarru G.P. Coenzyme Q10 and oxidative imbalance in Down syndrome: biochemical and clinical aspects. Biofactors 2008, 32:161-167.
8. Tomasetti M., Alleva R., Borghi B., Collins A.R. In vivo supplementation with Coenzyme Q10 enhances the recovery of human lymphocytes from oxidative DNA damage. FASEB J. 2001, 15:1425-1427.
9. Zana M., Janka Z., Kalman J. Oxidative stress: a bridge between Down's syndrome and Alzheimer's disease. Neurobiol. Aging 2007, 28:648-676.